{"title":"Cancer de la prostate: résumé des communications présentées au congrès American Urological Association (AUA) en 2007","authors":"J.-N. Cornu , M. Rouprêt","doi":"10.1016/S0003-4401(07)80016-7","DOIUrl":null,"url":null,"abstract":"<div><p>Five hundred and twenty one abstracts (26.51 %) were dedicated to prostate cancer during the 2007 annual meeting of the American Urological Association (AUA) which took place in Anaheim from 19-24th of May. The aim of the current article was to provide a summary of the most debated topics and to highlight the most original subjects in this specific field of urology. This year, the main topics of prostate cancer were diversified and concern notably : statin treatment, PSA kinetic, surgical margins, robotic surgery, molecular markers from bodily fluids and adjuvant therapy after surgery.</p></div>","PeriodicalId":50783,"journal":{"name":"Annales D Urologie","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2007-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0003-4401(07)80016-7","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales D Urologie","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0003440107800167","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Five hundred and twenty one abstracts (26.51 %) were dedicated to prostate cancer during the 2007 annual meeting of the American Urological Association (AUA) which took place in Anaheim from 19-24th of May. The aim of the current article was to provide a summary of the most debated topics and to highlight the most original subjects in this specific field of urology. This year, the main topics of prostate cancer were diversified and concern notably : statin treatment, PSA kinetic, surgical margins, robotic surgery, molecular markers from bodily fluids and adjuvant therapy after surgery.